Sources | Names Used |
---|---|
GDSC1000 | THZ-2-102-1 |
PharmacoGx | THZ-2-102-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRO | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CSTB | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | UBXN2B | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
mRNA | ALPPL2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | CLDN3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | UBTD1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | NR1H2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | C11orf58 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
mRNA | NDUFS5 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
mRNA | GPX7 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |